| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.181.264 | 4.137.279 | 4.207.010 | 4.774.810 | 5.100.930 | 4.875.529 | 4.542.032 | 4.350.290 | 5.285.012 | 5.655.223 |
| Total Income - EUR | 4.193.751 | 4.146.510 | 4.212.902 | 4.791.479 | 5.130.759 | 4.890.016 | 4.551.315 | 4.357.453 | 5.292.622 | 5.680.691 |
| Total Expenses - EUR | 4.279.652 | 4.331.913 | 4.211.862 | 4.949.519 | 5.196.238 | 4.981.413 | 4.705.449 | 4.417.904 | 5.432.200 | 5.841.731 |
| Gross Profit/Loss - EUR | -85.901 | -185.402 | 1.040 | -158.040 | -65.479 | -91.397 | -154.133 | -60.451 | -139.577 | -161.040 |
| Net Profit/Loss - EUR | -85.901 | -185.402 | -372 | -158.040 | -65.479 | -91.397 | -154.133 | -60.451 | -139.577 | -161.040 |
| Employees | 52 | 56 | 48 | 40 | 39 | 35 | 34 | 32 | 33 | 32 |
Check the financial reports for the company - Bendis Pharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 256.153 | 198.193 | 136.158 | 126.304 | 108.339 | 69.887 | 87.529 | 147.501 | 189.502 | 165.100 |
| Current Assets | 2.584.521 | 2.274.104 | 2.207.294 | 2.268.240 | 2.341.783 | 2.012.733 | 1.627.209 | 1.591.920 | 1.876.503 | 1.807.732 |
| Inventories | 105.863 | 65.260 | 72.394 | 177.623 | 384.566 | 184.050 | 203.413 | 189.469 | 192.887 | 159.741 |
| Receivables | 2.448.364 | 2.107.887 | 2.092.538 | 2.068.685 | 1.920.297 | 1.785.122 | 1.412.437 | 1.387.237 | 1.676.294 | 1.610.356 |
| Cash | 30.295 | 100.956 | 42.362 | 21.932 | 36.920 | 43.560 | 11.359 | 15.215 | 7.322 | 37.634 |
| Shareholders Funds | -152.198 | -336.047 | -330.733 | -482.703 | -538.834 | -646.929 | -786.717 | -849.609 | -986.610 | -1.142.136 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.994.492 | 2.809.838 | 2.683.684 | 2.877.621 | 2.994.111 | 2.732.400 | 2.511.000 | 2.597.086 | 3.062.751 | 3.125.302 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Bendis Pharm S.r.l.